• FR

IFCT-1003

Publications:
  • Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial
  • Randomized phase II trial evaluating treatment with EGFR-TKI versus EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial
  • Synopsis: IFCT-1003_Synopsis_1.4_140415.pdf

    Intergroupe Francophone de Cancérologie Thoracique

    Siège social
    10 rue de la Grange-Batelière
    75009 PARIS

    Standard : 01.56.81.10.45
    Recherche Clinique : 01.56.81.10.46

    Informations

    • Mentions légales
    • Avertissement
    • Plan du site

    Suivez-nous

    • Twitter
    • LinkedIn
    © IFCT 2021 - IFCT_TOUS_DROITS_RESERVES
    Contact Devenir membre Espace membre E-lettre Deconnexion